Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
UK Exceeds 600,000 COVID-19 Tests Genomically Sequenced
The UK has today (Friday 2 July) surpassed another important milestone in the fight against […]
Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell […]
SCAS CPR Resuscitation and Defibrillator App Save a Life Sees Spike in Downloads
An ambulance service app which provides cardiopulmonary resuscitation (CPR) guidance and locates the nearest defibrillator […]
WHO/Europe Launches New Monitoring Tool, Tracking Rates of COVID-19 in UEFA Euro 2020 Host Cities
With the UEFA European Football Championships being played in cities across the WHO European Region, […]
Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies, in Parallel with Achievement of Phase 1 Clinical Milestone
Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic […]
90% of UK’s Leading Health Providers Accelerate Digital Transformation Plans in Response to Covid-19
The UK health sector is fast accelerating its digital transformation plans in response to the […]
Electroducer Announces Major Medical Advance in Treatment of Heart Valve Disease; Raises €3 Million to Market its Device in Europe and US – Commencing in 2022
Electroducer, the designer and developer of the innovative medical device Electroducer Sleeve®, which treats heart […]
COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research […]
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
OnCusp Therapeutics (or “OnCusp”), a global biopharmaceutical company focused on translating cutting-edge research assets into […]
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more